Place two packs of CBD seeds beside each other, one marked 1:1 and the other 20:1, and the two look identical: same breeder’s packaging, the same seed count, contents which no eye can separate apart. Grow them in the same tent and they go their separate ways from the very first step and do not converge again. The cause is a single gene, and the clearest way to understand what it does is to follow the two packs along each step both share: the breeding that made them, the seed, the seedling, the flower tent, the cut, the jar, the lab report and the law. The ratios quoted as examples below are drawn from the range at https://calmcbdseeds.com, and that range runs 1:1, 2:1 and 20:1 with a highest line at about 30 to one; the biology holds the same regardless of which shop the seeds come from.
Stage One: At the Breeder’s Bench
Cannabis decides if it will produce THC or CBD at one position on the genome. The gene there comes in two forms: one codes the enzyme that turns the common starting molecule into THCA, the other the enzyme that converts it into CBDA. Each plant holds two copies, one inherited from each parent, and the combination fixes the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies give a CBD-dominant one. One of each gives a balanced plant, since the two forms are codominant and not one of them overrides the other.
The balanced pack was bred by crossing two balanced plants, each carrying one copy of each version. The CBD-dominant pack was made by crossing two plants that both carry two CBD copies and no THC copy between them. This one difference at the bench decides everything downstream, and it is already in the seed long before it is packed.
Stage Two: Inside the Seed
Cross two balanced plants and the seeds fall themselves by the oldest arithmetic in genetics: a quarter get two THC copies, a quarter inherit two CBD copies, half get one of each. In a pack of 10 seeds that works out to, on average, around two THC-dominant seeds, around two CBD-dominant ones, and five true balanced ones. The pack is sold by its parents, and in the case of half its contents the label is accurate; in the case of the other half it is a description of something else. Calm CBD Seeds states the expected split on every balanced line, so the buyer knows ahead of planting that a portion of the plants will depart from the headline ratio.
The CBD-dominant pack has no such spread. Every seed got a CBD copy from both parent, every plant will be CBD-dominant, and the ratio on the foil applies to all of them, give or take the ordinary variation in how total cannabinoid an given plant builds. The trade describe such lines “breed true” for chemotype; the term refers to exactly this absence of surprise.
Stage Three: The Seedling Tray
At this stage the two packs look the same once more, and the resemblance lasts further than most growers expect. Chemotype shows no mark on a seedling. Leaf shape, vigour, internode spacing and the speed of growth rate are governed by different genes altogether, and the three chemotypes of plant in the balanced pack come up indistinguishably beside one another and from every plant in the CBD-dominant pack.
The one practical distinction at this stage arises from ancestry rather than chemotype. Strains with strong hemp genetics, which covers some older CBD-dominant lines, are inclined to grow rangier and branch more sparsely. A well-worked 20:1 line grows like a normal indoor hybrid; a young one still carry the hemp in its frame. Not one of these habit says a thing about the ratio to come.
Frost, Smell and the Wrong Conclusions
In flower the two packs start to give clues, and the majority of them point the wrong way. Resin coverage is the first one a grower judges, and it was a fair guide: early CBD-dominant lines carried markedly less resin than their THC counterparts, a inheritance from hemp. Current lines have largely closed that gap, and a less resinous plant from the CBD-dominant pack can still test precisely where the foil said. Trichome density and chemotype are inherited on separate genes.
Smell is an even poorer guide. The terpene chemistry lives on yet different genes, so the THC-dominant plant hiding in the balanced pack can smell indistinguishable to the balanced one beside it, and either can be indistinguishable to a plant from the CBD-dominant pack. Growers who try to separate a balanced pack by nose in week eight are right about half the time, which is no better than leaving the plants unsorted at all.
Stage Five: The Harvest Window
Here the two packs differ in a manner that favours the grower of the CBD-dominant pack and also the CBD-dominant plants hidden in the balanced pack. CBDA breaks down rather slowly than THCA, so a CBD-dominant plant allowed a week beyond its peak retains the bulk of its cannabinoid content, where a THC-dominant one in the same neglect has already begun converting THC to CBN. The cloudy guidance nonetheless applies; it holds on account of the terpenes, which fade on any plant regardless the chemotype, and a late, over-dried CBD flower smells of little however good the lab number is.
Why Each Plant Gets Its Own Label
The CBD-dominant pack goes into one jar. Every plant in it holds roughly the same ratio, and blending them changes nothing anyone would notice. The balanced pack should never be handled that way. Pool its 10 plants in a single jar and the contents is a ratio that no foil could have predicted, skewed by whichever plants grew most, and nothing on a later test can untangle what went in.
The habit that prevents the trouble is almost tedious: harvest the balanced pack plant by plant, cure each separately, label each, and test them one at a time rather than after anything is combined. This is the only stage in the entire grow where the different kinds of plant in the balanced pack can still be told apart short of a laboratory, and then only for the reason that each is at that moment in its own container.
Reading the Two Results
Submit a sample from each jar to a laboratory and the two packs at last become readable. For the CBD-dominant pack the reports come back clustered tightly near the stated ratio, differing mostly in total output rather than in proportion. For the balanced pack they arrive back in three groups: some reports with almost all THC, a few with almost all CBD, and the majority somewhere near one to one. Nothing of this result is a failure; it is the breeder’s cross expressed as numbers.
Over-the-counter test kits exist for growers without a lab, and the majority of them show whether THC is there but not how much. That is enough to pull the THC-dominant jars away from a balanced pack and not enough to put a ratio to the others, and that suits the most frequent need: knowing what of the 10 jars will catch out someone.
Hemp Threshold Versus Chemotype
The last place where the two packs separate is in law, and it trips growers who assumed “CBD” was shorthand for “hemp”. The majority of countries define hemp by a THC ceiling, a fraction of a percent of dry weight, with the exact number differing by country and sometimes over time. A plant from the CBD-dominant pack producing twenty percent CBD at twenty to one at the same time makes around one percent THC, and that is several times over the majority of limits. Compliant cultivars are bred to hold total cannabinoid content down so the THC share stays under the line at harvest; CBD seed lines are selected for high output and allow the THC rise with it. A shop that gives only a ratio is selling a flower line; a grower who requires a compliant crop needs to look for a tested THC figure at maturity and order no line that cannot show one.
Past the threshold issue, the chemotype changes nothing in the law on the seed itself. In places where owning cannabis seeds is permitted and germinating them is not, the balanced pack and the CBD-dominant pack sit under the same rule as every other pack. In places where the plant is legal without restriction, the choice between them is a matter of preference and nobody else’s. No part of this page is legal advice, and the law that applies is the one where the seed will be sown, not the one where it was sold.